Beximco Pharma has a portfolio of over 500 products across broad therapeutic categories, including high-tech specialized products which are difficult to imitate. The large portfolio addresses a wide range of health issues and has been built through Beximco Pharma consistently expanding its offerings. Beximco Pharma produces over 500 products in its portfolio across many medical categories.
Beximco Pharma has a portfolio of over 500 products across broad therapeutic categories, including high-tech specialized products which are difficult to imitate. The large portfolio addresses a wide range of health issues and has been built through Beximco Pharma consistently expanding its offerings. Beximco Pharma produces over 500 products in its portfolio across many medical categories.
Beximco Pharma has a portfolio of over 500 products across broad therapeutic categories, including high-tech specialized products which are difficult to imitate. The large portfolio addresses a wide range of health issues and has been built through Beximco Pharma consistently expanding its offerings. Beximco Pharma produces over 500 products in its portfolio across many medical categories.
• Beximco Pharma is consistently building upon its portfolio and
currently producing more than 500 products encompassing broad therapeutic categories and the Company has created strong differentiation by offering a range of high-tech, specialized products which are difficult to imitate. • With a portfolio of over 500 products by Beximco pharmaceuticals, bid adieu to a wide range of Health issues. Beximco group with a portfolio of over 500 products
Paras Biopharmaceuticals Successfully Develops Cytofold StructQuant® Technology For Cytoplasmic Disulphide Formation, (For Active Folding) For Complex Therapeutic Protein